Ursodeoxycholic Acid
A Real-World Evidence Study to Evaluating the Safety and Effectiveness of Ursodeoxycholic Acid at various clinics across India.
BASIC DETAILS
Eligibility of the subjects
| Please tick (✔) as applicable | |||
|---|---|---|---|
| Yes | No | ||
| 1 | Male or female subjects within the age group 18 or above |
|
|
| 2 | Subject Diagnosed with Diagnosed with primary biliary cholangitis (PBC), primary sclerosing cholangitis (PSC), or other conditions for which Ursodeoxycholic Acid is prescribed. |
|
|
| 3 | Prescribed Ursodeoxycholic Acid as part of routine clinical care. |
|
|
| 4 | Available clinical records and follow-up data. |
|
|
Demographic data
Diagnosis and treatment details
Baseline symptoms (Before use of Ursodeoxycholic Acid)
Post treatment symptoms
Laboratory Tests
| ALT | AST | ALP | Bilirubin Levels | |
|---|---|---|---|---|
| Baseline Liver Function Tests |
|
|
|
|
| Follow-Up Liver Function Tests |
|
|
|
|
Patient-Reported Outcomes
| Quality of life assessment (If applicable) | |
|---|---|
| Instrument Used |
|
| Baseline Score |
|
| Follow-Up Score |
|
Symptom Relief
Overall Satisfaction with Treatment